CLINICAL_TRIALS
trial_result
· 2017-02-13
Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery [Phase 3]
Summary
Completed Phase 3 trial assessing the efficacy and safety of a 30 mcg sublingual sufentanil tablet for postoperative pain after abdominal surgery.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Talphera, Inc | Conditions: Post-Operative Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-02-13